12th Annual Optimizing Clinical Trials Summit: Site Selection, Feasibility and Patient Recruitment

2 - 4 Oct 2018, London

The 12th Annual Optimizing Clinical Trials Summit: Site Selection, Feasibility, and Patient Recruitment is a unique opportunity to explore new insights in the field of clinical trials, technology implementation in clinical trials, conducting feasibility, and patient motivation.

Come and find the answers to all the questions about how will innovation in technology drive the clinical trial process into a new era, why is industry leveraging social media to identify potential patients, and how to find the right pharma-CRO partnerships. You will also hear about Risk-Based Monitoring, Protocol Challenges as well as about Patient Education/Awareness of Clinical Trials.

By attending this summit, you will access the first-hand learnings and valuable tips from the senior experts of major pharma companies when it comes to the Site Selection for Clinical Studies and Protocol Challenges.


Key Speakers

David Shalhevet

Associate Director, Clinical Project Manager

Teva Pharmaceutical Industries

Veronique Freund

Head of Europe and Asia Pacific - Clinical External Parties Quality Management


Faidra van der Wal

Associate Director Global Clinical Development Operations Trial Lead 

Janssen Pharmaceutical

Frank Berger

Head, Study Budget Center of Excellence

Boehringer Ingelheim

Rhona Will 

Associate Director, Global Clinical Project Leader


Marc Hoffman

Chief Medical Officer


Key topics

  • What are the main keys to a successful technology implementation into clinical trials?
  • How do social media influence the patient recruitment? 
  • What are the key success factors for sponsor - CRO partnerships? 
  • What is the current state of e-consent in clinical trials? 
  • What is the best way to manage strategic outsourcing providers?
  • How can Digital health programs such as electronic medication management (EMM) improve the safety and quality of healthcare?
  • How can clinical operations professionals effectively address considerations for multi-company collaborations?
  • What are the main techniques for improving clinical trial retention?


Who Should attend

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from Pharmaceutical industry involved in:

  • Clinical Program Management
  • Clinical Operations
  • Europe Clinical Operations
  • EU Study Start Up Unit
  • Global Clinical Research
  • Development Operations
  • Clinical Research
  • Patient and Investigator Relations
  • Medical Affairs
  • Global Feasibility Operations

  • Clinical Pharmacology
  • Clinical Trials
  • Global Clinical Development
  • Clinical Program Director
  • Medical Director
  • Global Project Management
  • Clinical Research
  • Clinical Site Management
  • Patient Recruitment 

Register for event



Allan Lloyds Group
Trnavska cesta 82, 821 02 Bratislava, Slovakia

+421 221 025 322


Follow us